Skip to contentS
SeaStar Medical Holding Corp
S
ICUCWSeaStar Medical Holding Corp Q2 2025 · 10-Q
Revenue$338.00K$338.00K— vs Q2 2024 Net Income-$2.00M-$2.00MN/M vs Q2 2024 EPS Diluted-$0.18-$0.18N/M vs Q2 2024 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
SeaStar Medical Holding Corp · CIK 1831868 · Engraved from SEC EDGAR
Operating Cash Flowderived-$3,007,000N/M Margins · derivedGross margin92.0%
Operating margin-519.5%
Net margin-592.3%
ended Jun 30, 2025 · filed Aug 13, 2025 · 44 d after period end